diacerein has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, A; Huang, L; Li, Y; Luo, M; Lv, D; Shen, J; Xue, Y | 1 |
| El-Sherbiny, M; Helal, MG; Said, E; Salem, HA; Samaha, MM | 1 |
2 other study(ies) available for diacerein and Alloxan Diabetes
| Article | Year |
|---|---|
Diacerein attenuates vascular dysfunction by reducing inflammatory response and insulin resistance in type 2 diabetic rats.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Aorta, Thoracic; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Insulin Resistance; Male; Molecular Structure; NF-kappa B; Nitric Oxide Synthase; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Diacerein versus adipoRon as adiponectin modulators in experimentally-induced end-stage type 2 diabetes mellitus in rats.
Topics: Adiponectin; Adipose Tissue; Animals; Anthraquinones; Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Male; Muscle, Skeletal; Piperidines; Rats, Sprague-Dawley | 2022 |